Astera Labs, Inc. (ALAB) Balance Sheet
ALAB balance sheet, 2025
December 31, 2025 · U.S. dollars$1.53B assets = $168.2M liabilities + $1.36B equity
Both columns are drawn to the same scale: what ALAB owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ALAB financial health
Descriptive bands, not a rating. Fiscal 2025.
ALAB balance sheet trends, 2022–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $211.7M2022 | $1.53B2025 | +93.4%/yr | |
| Total liabilities | $297.0M2022 | $168.2M2025 | −17.3%/yr | |
| Shareholders’ equity | −$85.3M2022 | $1.36B2025 | — | |
| Cash & short-term investments | $163.1M2022 | $1.19B2025 | +93.9%/yr | |
| Total debt | $1.6M2022 | $35.1M2025 | +180.2%/yr | |
| Net cash (debt) | $161.5M2022 | $1.15B2025 | +$992.1M | |
| Working capital | $165.9M2022 | $1.23B2025 | +$1.1B | |
| Book value per share | −$0.652022 | $7.592025 | — | |
| Debt / equity | 0.022023 | 0.032025 | +0.01 | |
| Shares outstanding | 130.5M2022 | 179.6M2025 | +11.2%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ALAB assets
ALAB liabilities and equity
ALAB debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ALAB balance sheet
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | $1.19B | $914.3M | $149.3M | $163.1M |
| Cash & equivalents | $167.6M | $79.6M | $45.1M | $76.1M |
| Short-term investments | $1.02B | $834.8M | $104.2M | $87.1M |
| Receivables | $83.2M | $38.8M | $8.3M | $10.7M |
| Inventory | $59.0M | $43.2M | $24.1M | $28.9M |
| Other current assets | $31.0M | $16.7M | $4.1M | $3.3M |
| Total current assets | $1.36B | $1.01B | $185.8M | $206.0M |
| Property, plant & equipment (net) | $92.0M | $35.7M | $7.6M | $3.5M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 |
| Other non-current assets | $77.8M | $5.9M | $2.9M | $2.2M |
| Total assets | $1.53B | $1.05B | $196.3M | $211.7M |
| Liabilities | ||||
| Accounts payable | $42.4M | $26.9M | $6.3M | $10.3M |
| Short-term debt | — | $1.3M | $2.2M | $1.6M |
| Deferred revenue | — | $15.0M | −$13.1M | — |
| Total current liabilities | $133.0M | $86.5M | $35.1M | $40.1M |
| Long-term debt | $0 | $0 | $0 | $0 |
| Lease obligations | $4.1M | $1.3M | $2.2M | $1.6M |
| Other long-term liabilities | $35.1M | $3.2M | $3.8M | $256.9M |
| Total liabilities | $168.2M | $89.7M | $38.9M | $297.0M |
| Shareholders' equity | ||||
| Common stock & paid-in capital | $17,000 | $16,000 | $4,000 | $4,000 |
| Retained earnings (deficit) | $10.3M | −$208.8M | −$125.4M | −$99.1M |
| Accumulated other comprehensive income | $4.3M | $426,000 | $259,000 | −$229,000 |
| Total shareholders' equity | $1.36B | $964.8M | $157.4M | −$85.3M |
| Key figures | ||||
| Total debt | $35.1M | $1.3M | $2.9M | $1.6M |
| Net cash (debt) | $1.15B | $913.0M | $146.4M | $161.5M |
| Working capital | $1.23B | $926.4M | $150.7M | $165.9M |
| Tangible book value | $1.36B | $964.8M | $157.4M | −$85.3M |
| Book value per share | $7.59 | $7.35 | $1.03 | −$0.65 |
| Shares outstanding | 179.6M | 131.3M | 152.5M | 130.5M |
| Current ratio | 10.24 | 11.71 | 5.30 | 5.14 |
| Quick ratio | 9.56 | 11.01 | 4.49 | 4.34 |
| Debt / equity | 0.03 | 0.00 | 0.02 | — |
| Equity / assets | 89.0% | 91.5% | 80.2% | −40.3% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & short-term investments | $1.25B | $1.18B | $1.19B | $1.13B | $1.07B | $924.7M | $914.3M | $886.8M | $831.0M | $801.4M | $149.3M |
| Cash & equivalents | $111.5M | $148.3M | $167.6M | $140.4M | $162.3M | $86.4M | $79.6M | $126.1M | $421.1M | $696.1M | $45.1M |
| Short-term investments | $1.14B | $1.04B | $1.02B | $994.0M | $902.8M | $838.3M | $834.8M | $760.7M | $409.9M | $105.3M | $104.2M |
| Receivables | $192.5M | $134.8M | $83.2M | $42.9M | $24.3M | $69.8M | $38.8M | $25.4M | $22.2M | $16.8M | $8.3M |
| Inventory | $113.8M | $60.2M | $59.0M | $51.7M | $58.6M | $51.1M | $43.2M | $24.4M | $28.6M | $29.6M | $24.1M |
| Other current assets | $92.7M | $33.5M | $31.0M | $61.2M | $32.7M | $30.3M | $16.7M | $9.0M | $9.4M | $6.7M | $4.1M |
| Total current assets | $1.65B | $1.41B | $1.36B | $1.29B | $1.18B | $1.08B | $1.01B | $945.6M | $891.2M | $854.4M | $185.8M |
| Property, plant & equipment (net) | $119.3M | $97.2M | $92.0M | $72.5M | $62.1M | $39.5M | $35.7M | $35.1M | $21.8M | $7.6M | $4.7M |
| Goodwill & intangible assets | $91.6M | $87.7M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $68.8M | $61.4M | $77.8M | $38.5M | $28.6M | $6.4M | $5.9M | $2.3M | $2.4M | $2.9M | $5.8M |
| Total assets | $1.93B | $1.66B | $1.53B | $1.40B | $1.27B | $1.12B | $1.05B | $983.1M | $915.5M | $864.9M | $196.3M |
| Liabilities | |||||||||||
| Accounts payable | $53.9M | $55.8M | $42.4M | $25.8M | $31.6M | $29.5M | $26.9M | $18.6M | $14.6M | $11.5M | $6.3M |
| Short-term debt | — | $5.7M | — | $4.4M | $4.7M | — | $1.3M | — | $2.1M | $2.3M | $2.2M |
| Deferred revenue | — | — | — | — | $10.0M | $15.0M | $15.0M | $10.0M | $5.0M | $10.2M | — |
| Total current liabilities | $164.3M | $125.0M | $133.0M | $101.0M | $106.4M | $77.3M | $86.5M | $88.0M | $64.1M | $45.6M | $35.1M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | — | $4.1M | — | — | — | $1.3M | — | $2.1M | $2.3M | $2.2M |
| Other long-term liabilities | $41.5M | $40.2M | $35.1M | $28.5M | $29.3M | $2.9M | $3.2M | $5.4M | $6.2M | $10.5M | $258.9M |
| Total liabilities | $205.8M | $165.3M | $168.2M | $129.5M | $135.7M | $80.1M | $89.7M | $93.5M | $70.3M | $56.1M | $294.0M |
| Shareholders' equity | |||||||||||
| Common stock & paid-in capital | $17,000 | $17,000 | $17,000 | $17,000 | $17,000 | $16,000 | $16,000 | $16,000 | $16,000 | $16,000 | $4,000 |
| Retained earnings (deficit) | $243.7M | $90.6M | $10.3M | −$34.6M | −$125.8M | −$177.0M | −$208.8M | −$233.5M | −$225.9M | −$218.4M | −$125.4M |
| Accumulated other comprehensive income | −$3.4M | −$780,000 | $4.3M | $4.1M | $2.9M | $2.0M | $426,000 | $4.4M | −$352,000 | −$59,000 | $259,000 |
| Total shareholders' equity | $1.73B | $1.49B | $1.36B | $1.27B | $1.14B | $1.04B | $964.8M | $889.6M | $845.3M | $808.8M | −$97.7M |
| Key figures | |||||||||||
| Total debt | — | $41.9M | $35.1M | $58.2M | $32.3M | — | $1.3M | — | $2.1M | $2.3M | $2.2M |
| Net cash (debt) | — | $1.14B | $1.15B | $1.08B | $1.03B | — | $913.0M | — | $828.9M | $799.1M | $147.2M |
| Working capital | $1.49B | $1.29B | $1.23B | $1.19B | $1.07B | $998.5M | $926.4M | $857.5M | $827.2M | $808.9M | $150.7M |
| Tangible book value | $1.63B | $1.41B | $1.36B | $1.27B | $1.14B | $1.04B | $964.8M | $889.6M | $845.3M | $808.8M | −$97.7M |
| Book value per share | $9.47 | $8.25 | $7.53 | $7.04 | $6.38 | $5.85 | $5.43 | $5.67 | $5.45 | $5.26 | −$0.64 |
| Shares outstanding | 182.3M | 181.2M | 181.2M | 180.6M | 178.1M | 178.1M | 177.6M | 156.8M | 155.2M | 153.9M | 152.5M |
| Current ratio | 10.05 | 11.30 | 10.24 | 12.78 | 11.10 | 13.92 | 11.71 | 10.74 | 13.91 | 18.74 | 5.30 |
| Quick ratio | 8.80 | 10.55 | 9.56 | 11.66 | 10.24 | 12.87 | 11.01 | 10.36 | 13.32 | 17.95 | 4.49 |
| Debt / equity | — | 0.03 | 0.03 | 0.05 | 0.03 | — | 0.00 | — | 0.00 | 0.00 | — |
| Equity / assets | 89.3% | 90.0% | 89.0% | 90.8% | 89.3% | 92.9% | 91.5% | 90.5% | 92.3% | 93.5% | −49.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 20, 2026); data from EODHD.
ALAB financial position
At the end of fiscal 2025 (December 31, 2025), Astera Labs had total assets of $1.5 billion (up 45.3% from a year earlier), total liabilities of $168.2 million and shareholders' equity of $1.4 billion. It held $1.2 billion in cash and short-term investments against $35.1 million of debt, a net cash position of $1.2 billion. Its current ratio was 10.24. In the latest quarter (ended June 30, 2026) total assets were $1.9 billion and equity $1.7 billion.
Related: ALAB income statement, ALAB cash flow statement, ALAB key metrics. See the ALAB stock overview for the latest quote and news.
ALAB balance sheet FAQ
What are Astera Labs's total assets?
Astera Labs reported total assets of $1.5 billion at the end of fiscal 2025 (December 31, 2025), compared with $1.1 billion a year earlier.
How much debt does Astera Labs have?
Astera Labs had $35.1 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.03.
How much cash does Astera Labs have?
Astera Labs held $1.2 billion in cash and short-term investments at the end of fiscal 2025; with $35.1 million of debt that is net cash of $1.2 billion.
What is Astera Labs's book value?
Astera Labs's shareholders' equity (book value) was $1.4 billion at the end of fiscal 2025, or $7.59 per share.
What is Astera Labs's current ratio?
Astera Labs had current assets of $1.4 billion and current liabilities of $133.0 million, a current ratio of 10.24 (it can cover its short-term obligations).